Octreotide as therapeutic option for congenital idiopathic chylothorax: A case series

Acta Paediatrica, International Journal of Paediatrics

Volumn 101, Issue 4, 2012, Pages

  Shah, Dharmesh ^a,c   Sinn, John K H ^b,c  

^a WESTMEAD HOSPITAL   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Chylothorax; Congenital; Octreotide

Indexed keywords

MEDIUM CHAIN FATTY ACID; MEDIUM CHAIN TRIACYLGLYCEROL; NITRIC OXIDE; OCTREOTIDE; TRIACYLGLYCEROL;

ABSENCE OF SIDE EFFECTS; ARTICLE; BIRTH WEIGHT; CHYLOTHORAX; CLINICAL ARTICLE; CONGENITAL DISORDER; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; EARLY INTERVENTION; ENTERIC FEEDING; FEMALE; FETUS HYDROPS; GESTATIONAL AGE; HIGH FREQUENCY OSCILLATION; HUMAN; IDIOPATHIC DISEASE; INFANT; MALE; NEONATAL RESPIRATORY DISTRESS SYNDROME; PLEURA EFFUSION; PLEURA FLUID; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; THORAX DRAINAGE; TREATMENT INDICATION; TREATMENT OUTCOME;

CHYLOTHORAX; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; MALE; OCTREOTIDE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84858070407     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2011.02529.x     Document Type: Article

References (35)

1. Eddlernan KA, Levine AB, Chitkara U, Berkowitz RL,. Reliability of pleural fluid lymphocyte counts in the antenatal diagnosis of congenital chylothorax. Obstet Gynecol 1991; 178: 530-2.
2. Prada Arias M, Rodriguez Barca P, Carbajosa Herrero MT, de Celis Villasana L, Vinals Gonzalez F,. Chylothorax following repair of oesophageal atresia: conservative treatment with octreotide. An Pediatr 2008; 69: 184-5.
3. Roehr CC, Jung A, Proquitte H, Blankenstein O, Hammer H, Lakhoo K, et al., Somatostatin or octreotide as treatment options for chylothorax in young children: a systematic review. Intensive Care Med 2006; 32: 650-7.
4. Paget-Brown A, Kattwinkel J, Rodgers BM, Michalsky MP,. The use of octreotide to treat congenital chylothorax. J Pediatr Surg 2006; 41: 845-7.
5. Rasiah SV, Oei J, Lui K,. Octreotide in the treatment of congenital chylothorax. J Paediatr Child Health 2004; 40: 585-8. (Pubitemid 39387561)
6. Das A, Shah PS,. Octreotide for the treatment of chylothorax in neonates. Cochrane Database Syst Rev 2010 DOI:.
7. Brissaud O, Desfrere L, Mohsen R, Fayon M, Demarquez JL,. Congenital idiopathic chylothorax in neonates: chemical pleurodesis with povidone iodine (Betadine). Arch Dis Child Fetal Neonatal Ed 2003; 88: F531-3. (Pubitemid 37449431)
8. Azizkan RG, Canfield J, Alford BA, Rodgers BM,. Pleuro peritoneal shunts in the management of neonatal chylothorax. J Pediatr Surg 1983; 18: 842-50. (Pubitemid 14175284)
9. Anderson EA, Hertel J, Pedersen SA, Sorensen SR,. Congenital chylothorax: management by ligature of the thoracic duct. Scand J Thorac Cardiovasc Surg 1984; 18: 193-4. (Pubitemid 15191186)
10. Browse NL, Allen DR, Wilson NM,. Management of chylothorax. Br J Surg 1997; 84: 1711-6. (Pubitemid 27519602)
11. Lam JC, Aters S, Tobias JD,. Initial experience with octreotide in the pediatric population. Am J Ther 2001; 8: 409-15. (Pubitemid 33753136)
12. Rocha G, Henriques Coelho T, Correia Pinto J, Guedes MB, Guimares H,. Octreotide for conservative management of postoperative chylothorax in the neonate. Acta Med Port 2007; 20: 467-70. (Pubitemid 351428519)
13. Stajich GV, Ashworth L,. Octreotide. Neonatal Netw 2006; 25: 365-9.
14. Laje P, Halaby L, Adzick NS, Stanley CA,. Necrotizing enterocolitis in neonates receiving octreotide for the management of congenital hyperinsulinism. Pediatr Diabetes 2010; 11: 142-7.
15. Bulbul A, Okan F, Nuhoglu A,. Idiopathic congenital chylothorax presented with severe hydrops and treated with octreotide in term newborn. J Matern Fetal Neonatal Med 2009; 22: 1197-200.
16. Pisek GR,. Report of a case of chylothorax. Arch Pediatr 1917; 34: 929.
17. Stewart CA, Linner HP,. Chylothorax in the newborn infant, report of a case. Am J Dis Child 1926; 31: 654-6.
18. Beghetti M, La Scala G, Belli D, Bugmann P, Kalangos A, Le Coultre C,. Etiology and management of pediatric chylothorax. J Pediatr 2000; 136: 653-8. (Pubitemid 30318397)
19. Apak RA, Yurdakok M, Oran O, Senocak ME, Caglor M,. Preoperative use of octreotide in a newborn with persistent hyperinsulinemic hypoglycemia of infancy. J Pediatr Endocrinol 1998; 11 (Suppl 1): 143-5.
20. Rimensberger PC, Muller-Schenker B, Kalangos A, Beghetti M,. Treatment of a persistent postoperative chylothorax with somatostatin. Ann Thorac Surg 1998; 66: 253-4. (Pubitemid 28389274)
21. Sivasli E, Dogru D, Aslan AT, Yurdakok M, Tekinalp G,. Spontaneous neonatal chylothorax treated with octreotide in Turkey: a case report. J Perinatol 2004; 24: 261-2. (Pubitemid 38500071)
22. Young S, Dalgleish S, Eccleston A, Akierman A, McMillan D,. Severe congenital chylothorax treated with octreotide. J Perinatol 2004; 24: 200-2. (Pubitemid 38515163)
23. Helin RD, Angeles ST, Bhat R,. Octreotide therapy for chylothorax in infants and children: A brief review. Pediatr Crit Care Med 2006; 7: 576-9. (Pubitemid 44715298)
24. Goto M, Kawamata K, Kitano M, Watanabe K, Chiba Y,. Treatment of chylothorax in a premature infant using somatostatin. J Perinatol 2003; 23: 563-4. (Pubitemid 37428167)
25. Parames F, Freitas I, Fragata J, Trigo C, Pinto MF,. Octreotide- additional conservative therapy for postoperative chylothorax in congenital heart disease. Rev Port Cardiol 2009; 28: 799-807.
26. Buck M,. Octreotide for management of chylothorax in infants and children. Paediatr Pharmacother. Children's Medical Center, University of Virginia, 2004; 10: 10.
27. Mohseni-Bod H, Macrae D, Slavik Z,. Somatostatin analog (octreotide) in management of neonatal postoperative chylothorax: is it safe? Pediatr Crit Care Med 2004; 5: 356-7.
28. Arevalo RP, Bullabh P, Krauss AN, Auld PA, Spigland N,. Octreotide-induced hypoxaemia and pulmonary hypertension in premature neonates. J Pediatr Surg 2003; 38: 251-3. (Pubitemid 36160077)
29. Reck-Burneo CA, Parekh A, Velcek FT,. Is octreotide a risk factor in necrotizing enterocolitis? J Pediatr Surg 2008; 43: 1209-10. (Pubitemid 351814924)
30. Radetti G, Gentili L, Paganini C, Messner H,. Cholelithiasis in a newborn following treatment with the somatostatin analogue octreotide. Eur J Pediatr 2000; 159: 550. (Pubitemid 30419010)
31. Higgins RD, Yan Y, Schrier BK,. Somatostatin analogs inhibit neonatal retinal neovascularization. Exp Eye Res 2002; 74: 553-9. (Pubitemid 34757010)
32. Copons Fernandez C, Benifez Segura I, Castillo Salinas F, Salcedo Abizanda S,. Neonatal chylothorax: aetiology, clinical course and efficacy of treatment. An Pediatr 2008; 68: 224-31. (Pubitemid 351468558)
33. Siu SL, Lam DS,. Spontaneous neonatal chylothorax treated with octreotide. J Paediatr Child Health 2006; 42: 65-7.
34. Andreou A, Papouli M, Papavasiliou V, Badouraki M,. Postoperative chylous ascites in a neonate treated successfully with octreotide: bile sludge and cholestasis. Am J Perinatol 2005; 22: 401-4. (Pubitemid 41688413)
35. Sahin Y, Aydin D,. Congenital chylothorax treated with octreotide. Indian J Pediatr 2005; 72: 885-8. (Pubitemid 41652409)